Cancel

Links to sites outside of ahfzzx.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website and the website may not be appropriate for all audiences. 

To stay on the current website, select “Cancel”


Continue

You are leaving Takeda.com

Takeda - Global

EPD-3055 OneTrust Cookie

EPD-3519 Schema Script

EPD-2855 GTM Script

EPD-4037 Matomo Tag Manager

EPD-4268 Cookie Script Hack

Takeda provides annual and quarterly financial highlights, statements, and data for investors. Data are available to download in Excel format.

Financial Statements and Highlights | Takeda Investor Relations

Investor

# Financial Highlights



Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

## Sign up for our investors newsletter



Takeda today decided to increase the aggregate maximum purchase amount in respect of cash tender offers to purchase outstanding principal amount of notes issued by its subsidiaries. For the details, please see [here](http://assets-dam.ahfzzx.com/image/upload/Global/News_Room/Press_Release/2024/takeda-upsize-cash-tender-offers/takeda-upsize-cash-tender-offers-en.pdf).

Takeda today decided to increase the aggregate maximum purchase amount in respect of cash tender offers to purchase outstanding principal amount of notes issued by its subsidiaries. For the details, please see here.

Takeda Announces Upsize of Cash Tender Offers for Certain Outstanding Notes

Takeda today announced that it has determined the pricing of its unsecured U.S. dollar-denominated senior notes. For the details, please see [here](http://assets-dam.ahfzzx.com/image/upload/v1719521394/Global/News_Room/Press_Release/2024/takeda-announces-pricing-of-its-unsecured-us-dollar-denominated-senior-notes/kizuna-pricing-press-release-en.pdf).


Takeda today announced that it has determined the pricing of its unsecured U.S. dollar-denominated senior notes. 

Takeda Announces Pricing of its Unsecured U.S. Dollar-Denominated Senior Notes

Takeda today announced that it has commenced cash tender offers to purchase up to $1.0 billion outstanding principal amount of notes issued by its subsidiaries. For the details, please see [here](http://assets-dam.ahfzzx.com/image/upload/Global/News_Room/Press_Release/2024/takeda-announces-cash-tender-offers-for-up-to-1billion-outstanding-principal-amount-of-notes/kizuna-tender-offer-launch-press-release-en.pdf).

Takeda Announces Cash Tender Offers for up to $1.0 Billion Outstanding Principal Amount of Notes

**OSAKA, Japan, June 26, 2024 – Takeda ([TSE:4502/NYSE:TAK](http://0lvo.ahfzzx.com/investors/overview/))** today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”) on June 26, 2024. The Annual Report can be accessed on Takeda’s website at: [http://0lvo.ahfzzx.com/investors/sec-filings-and-security-reports/](/investors/sec-filings-and-security-reports/).

In addition, Takeda will also provide a hard copy of the Annual Report, which includes its most recent complete audited financial statements free of charge to any shareholder upon request. Please contact Takeda Investor Relations by e-mail at [takeda.ir.contact@ahfzzx.com](mailto:takeda.ir.contact@ahfzzx.com).


## About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
For more information, visit [0lvo.ahfzzx.com](/).


OSAKA, Japan, June 26, 2024 – Takeda (TSE:4502/NYSE:TAK) today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2024 (the “Annual Report”) with the U.S. Securities and Exchange Commission (the “SEC”) on June 26, 2024.